92 related articles for article (PubMed ID: 2662053)
21. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
22. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
23. Degradation of cholecystokinin octapeptide by the neutral endopeptidase EC 3.4.24.11 and design of proteolysis-resistant analogues of the peptide.
Najdovski T; de Pont JJ; Tesser GI; Penke B; Martinez J; Deschodt-Lanckman M
Neurochem Int; 1987; 10(4):459-65. PubMed ID: 20501118
[TBL] [Abstract][Full Text] [Related]
24. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra.
Benoliel JJ; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1992 Mar; 58(3):916-22. PubMed ID: 1310726
[TBL] [Abstract][Full Text] [Related]
25. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
[TBL] [Abstract][Full Text] [Related]
26. Characterization of proline endopeptidase from rat brain.
Andrews PC; Hines CM; Dixon JE
Biochemistry; 1980 Nov; 19(24):5494-500. PubMed ID: 6779865
[TBL] [Abstract][Full Text] [Related]
27. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
[TBL] [Abstract][Full Text] [Related]
28. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
[TBL] [Abstract][Full Text] [Related]
29. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors.
Llorens-Cortes C; Gros C; Schwartz JC
Eur J Pharmacol; 1985 Dec; 119(3):183-91. PubMed ID: 3912194
[TBL] [Abstract][Full Text] [Related]
30. Rapid degradation of D- and L-succinimide-containing peptides by a post-proline endopeptidase from human erythrocytes.
Momand J; Clarke S
Biochemistry; 1987 Dec; 26(24):7798-805. PubMed ID: 3480758
[TBL] [Abstract][Full Text] [Related]
31. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
32. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
Deschodt-Lanckman M; Strosberg AD
FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
[TBL] [Abstract][Full Text] [Related]
33. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
Browne P; O'Cuinn G
Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Law JK; Marabout B; Luthra PM; Moore AN; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2000 Feb; 43(4):664-74. PubMed ID: 10691692
[TBL] [Abstract][Full Text] [Related]
36. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
Acker GR; Molineaux C; Orlowski M
J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
[TBL] [Abstract][Full Text] [Related]
37. Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro.
Koulischer D; Moroder L; Deschodt-Lanckman M
Regul Pept; 1982 Aug; 4(3):127-39. PubMed ID: 6291099
[TBL] [Abstract][Full Text] [Related]
38. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
Busby WH; Youngblood WW; Kizer JS
Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of thyrotropin-releasing hormone (TRH) and (3Me-His) TRH by brain peptidases studied by high-performance liquid chromatography.
Griffiths EC; McDermott JR; Smith AI
Neurosci Lett; 1982 Jan; 28(1):61-5. PubMed ID: 6121306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
